Through loss-of-function experiments, we established that ANXA1 acts as a tumor suppressor in OSCCs, particularly in CAL27 cells with a stem cell phenotype, because its downmodulation restored the motility and resulted in a more aggressive phenotype. The gene discussed is ANXA1; the disease is neoplasm.